Is guselkumab known to pass into human breast milk?

It is unknown whether guselkumab (Tremfya) passes into human milk; human IgGs enter milk during the first days after birth and then decrease, so infant risk during this period cannot be excluded, and discontinuing breast-feeding or abstaining from therapy requires weighing benefits for the child and woman.